𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas

✍ Scribed by Øystein Fluge; Lars A. Akslen; Dagny R.F. Haugen; Jan E. Varhaug; Johan R. Lillehaug

Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
604 KB
Volume
87
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EXPRESSION OF THE TYPE 1 TYROSINE KINASE
EXPRESSION OF THE TYPE 1 TYROSINE KINASE GROWTH FACTOR RECEPTORS EGF RECEPTOR, c-erbB2 AND c-erbB3 IN BLADDER CANCER
✍ RAJKUMAR, THANGARAJAN; STAMP, GORDON W. H.; PANDHA, HARDEV S.; WAXMAN, JONATHAN; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

Expression of the c-erbB3 protein was determined in transitional cell carcinoma of the bladder by immunohistochemistry. Strong membrane staining was observed in 10 per cent of cases (7/70) and cytoplasmic and membrane overexpression in 20 per cent (14/70). Overexpression of the epidermal growth fact

Expression ofMet protein and urokinase-t
Expression ofMet protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid
✍ Zanetti, Antonio; Stoppacciaro, Antonella; Marzullo, Antonella; Ciabatta, Maria; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

Met protein encoded by MET oncogene is the high affinity receptor for hepatocyte growth factor (HGF)/scatter factor (SF). HGF/SF has to be cleaved in its heterodimeric form by the urokinase-type plasminogen activator (uPA) to become active as a ligand for Met receptor. The expression of Met protein

Hypermethylation, but not LOH, is associ
Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma
✍ Ying Huang; Albert de la Chapelle; Natalia S. Pellegata 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 494 KB 👁 1 views

## Abstract We previously obtained gene expression profiles of 8 matched papillary thyroid carcinoma (PTC) and normal tissues using DNA microarrays. To identify novel tumor suppressor genes involved in thyroid carcinogenesis, we here analyze genes showing lower expression in PTC tumors than in norm

Changes of expression level of the diffe
Changes of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptor
✍ Katsuhiro Tanaka; Hiroshi Sonoo; Yutaka Yamamoto; Kiyoshi Udagawa; Hironori Kuni 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

Background and Objectives: Differences in the expression levels of Thyroglobulin (Tg), Thyroid peroxidase (TPO) and thyrotropin receptor (TSH-R) in primary and recurrent specimens under a suppressive serum TSH condition were elucidated in 26 papillary carcinoma patients. Methods: Immunohistochemical